Having trouble accessing articles? Reset your cache.

Juvista avotermin: Phase I data

In a U.S. Phase I trial in 50 patients, escalating doses of Juvista injected into the margins of a wound

Read the full 201 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE